Published in Anticancer Drugs on March 01, 2015
Topological robustness analysis of protein interaction networks reveals key targets for overcoming chemotherapy resistance in glioma. Sci Rep (2015) 0.78
A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients. J Neurosurg Anesthesiol (2017) 0.75
Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots. Prog Neurobiol (2015) 0.75
Aquaporin 4-Mediated Glutamate-Induced Astrocyte Swelling Is Partially Mediated through Metabotropic Glutamate Receptor 5 Activation. Front Cell Neurosci (2017) 0.75
The anticancer estrogen receptor antagonist tamoxifen impairs consolidation of inhibitory avoidance memory through estrogen receptor alpha. J Neural Transm (Vienna) (2017) 0.75
MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med (2005) 29.65
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol (2009) 25.96
Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol (1995) 3.53
Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res (1990) 3.38
Temozolomide and treatment of malignant glioma. Clin Cancer Res (2000) 2.95
New treatment strategies for malignant gliomas. Expert Rev Anticancer Ther (2006) 1.47
Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett (1994) 1.39
Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. Am J Pathol (2002) 1.29
The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation. Clin Cancer Res (2009) 1.25
O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells. Cancer Res (2007) 1.09
Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency. Toxicol Appl Pharmacol (2001) 1.01
Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021. Neuro Oncol (2006) 0.98
Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery (1991) 0.97
Modulation of mitochondrial Ca(2+) uptake by estrogen receptor agonists and antagonists. Br J Pharmacol (2005) 0.94
Noscapine inhibits tumor growth in TMZ-resistant gliomas. Cancer Lett (2011) 0.91
Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C. Neurosurgery (1992) 0.90
Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas. J Neurosurg (2004) 0.90
Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen. Clin Cancer Res (1996) 0.89
Tamoxifen (TAM): the dispute goes on. Ann Ist Super Sanita (2006) 0.85
Activation of c-Jun N-terminal kinase 1 and caspase 3 in the tamoxifen-induced apoptosis of rat glioma cells. J Cancer Res Clin Oncol (2004) 0.85
Activated JNK brings about accelerated apoptosis of Bcl-2-overexpressing C6 glioma cells on treatment with tamoxifen. J Neurochem (2005) 0.82
Adjuvant endocrine therapy for early breast cancer: the story so far. Cancer Invest (2010) 0.81
Continuous tamoxifen and dose-dense temozolomide in recurrent glioblastoma. Anticancer Res (2013) 0.80
Dual effect of tamoxifen, an anti-breast-cancer drug, on intracellular Ca(2+) and cytotoxicity in intact cells. Toxicol Appl Pharmacol (2000) 0.79
The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings. Anticancer Res (2002) 0.77
Tamoxifen in trimodal therapy with cytotoxic drugs and hyperthermia in vivo significantly enhance therapeutic efficacy against B16-F10 melanoma. Tumori (2012) 0.77
Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron (2007) 3.98
Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum. Nat Chem Biol (2008) 3.16
Choroidal thickness in both eyes of patients with unilateral idiopathic macular hole. Ophthalmology (2012) 2.78
Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A (2004) 2.15
Generation of simian-tropic HIV-1 by restriction factor evasion. Science (2006) 1.84
A macaque model of HIV-1 infection. Proc Natl Acad Sci U S A (2009) 1.76
Choroidal thickness in healthy Chinese subjects. Invest Ophthalmol Vis Sci (2011) 1.74
Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res (2004) 1.59
Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen (2002) 1.51
Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J Biol Chem (2009) 1.51
Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J Biol Chem (2011) 1.41
Pulmonary antrum radial-linear ablation for paroxysmal atrial fibrillation: interim analysis of a multicenter trial. Circ Arrhythm Electrophysiol (2013) 1.40
Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci U S A (2003) 1.37
A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein. PLoS One (2011) 1.36
Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. J Appl Physiol (1985) (2002) 1.35
De novo sequencing and analysis of root transcriptome using 454 pyrosequencing to discover putative genes associated with drought tolerance in Ammopiptanthus mongolicus. BMC Genomics (2012) 1.29
Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res (2004) 1.29
Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells. Brain Res (2006) 1.28
Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta (2009) 1.25
Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors. Biochem Biophys Res Commun (2004) 1.21
Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta (2006) 1.20
17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res (2005) 1.18
Reactive oxygen species-mediated TRPC6 protein activation in vascular myocytes, a mechanism for vasoconstrictor-regulated vascular tone. J Biol Chem (2011) 1.17
Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Oncol Rep (2012) 1.16
Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res (2005) 1.16
A method for generating uniform size-segregated pyrite particle fractions. Geochem Trans (2007) 1.16
Controlled electrochemical synthesis of conductive polymer nanotube structures. J Am Chem Soc (2007) 1.14
Nano-embossing technology on ferroelectric thin film Pb(Zr0.3,Ti0.7)O3 for multi-bit storage application. Nanoscale Res Lett (2011) 1.12
Methylene blue as a cerebral metabolic and hemodynamic enhancer. PLoS One (2012) 1.12
Estrogen actions on mitochondria--physiological and pathological implications. Mol Cell Endocrinol (2008) 1.11
Estrogen-like compounds for ischemic neuroprotection. Stroke (2004) 1.10
Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke (2012) 1.10
Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res (2004) 1.08
Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. J Biol Chem (2004) 1.07
Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation. Curr Eye Res (2006) 1.07
Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol Pharmacol (2006) 1.06
Investigation into the antioxidant activity and chemical composition of alcoholic extracts from defatted marigold (Tagetes erecta L.) residue. Fitoterapia (2011) 1.06
Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles. Int J Nanomedicine (2011) 1.05
SARS coronavirus induces apoptosis in Vero E6 cells. J Med Virol (2004) 1.05
Estrogen protects the inner retina from apoptosis and ischemia-induced loss of Vesl-1L/Homer 1c immunoreactive synaptic connections. Invest Ophthalmol Vis Sci (2003) 1.05
Diindolylmethane alters gene expression in human keratinocytes in vitro. J Nutr (2002) 1.02
Reversing the Warburg effect as a treatment for glioblastoma. J Biol Chem (2013) 1.02
Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke. J Pharmacol Exp Ther (2009) 1.02
Estrogen receptor beta as a mitochondrial vulnerability factor. J Biol Chem (2009) 1.02
Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature. Chin J Cancer (2011) 1.02
Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance. Int J Nanomedicine (2012) 1.01
Autophagy is activated and might protect neurons from degeneration after traumatic brain injury. Neurosci Bull (2008) 1.01
Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke (2002) 1.01
Reconstitution and characterization of eukaryotic N6-threonylcarbamoylation of tRNA using a minimal enzyme system. Nucleic Acids Res (2013) 1.00
A prototypical Sigma-1 receptor antagonist protects against brain ischemia. Brain Res (2007) 0.99
Neuroprotective actions of methylene blue and its derivatives. PLoS One (2012) 0.99
Histochemical staining and quantification of dihydrolipoamide dehydrogenase diaphorase activity using blue native PAGE. Electrophoresis (2007) 0.97
Subcellular distribution of native estrogen receptor alpha and beta subtypes in cultured human lens epithelial cells. Exp Eye Res (2004) 0.97
Dose dependence and therapeutic window for the neuroprotective effects of 17beta-estradiol when administered after cerebral ischemia. Neurosci Lett (2007) 0.96
Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens. Front Neuroendocrinol (2009) 0.96
Glutamate receptor activation evokes calpain-mediated degradation of Sp3 and Sp4, the prominent Sp-family transcription factors in neurons. J Neurochem (2007) 0.96
Pyruvate protects the brain against ischemia-reperfusion injury by activating the erythropoietin signaling pathway. Stroke (2012) 0.96
The use of estrogens and related compounds in the treatment of damage from cerebral ischemia. Ann N Y Acad Sci (2003) 0.95
Efficient inhibition of SIV replication in rhesus CD4+ T-cell clones by autologous immortalized SIV-specific CD8+ T-cell clones. Virology (2008) 0.95
Effects of subchronic exposure to multi-walled carbon nanotubes on mice. J Toxicol Environ Health A (2010) 0.94
Brainstem glioma progression in juvenile and adult rats. J Neurosurg (2008) 0.94
Displacement of particles in microfluidics by laser-generated tandem bubbles. Appl Phys Lett (2010) 0.93
Dynamics of catalytic tubular microjet engines: dependence on geometry and chemical environment. Nanoscale (2011) 0.92
Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl)methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model. Mol Pharm (2010) 0.92
Highly flexible pseudocapacitor based on freestanding heterogeneous MnO2/conductive polymer nanowire arrays. Phys Chem Chem Phys (2012) 0.92
Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis. Cancer Epidemiol Biomarkers Prev (2013) 0.92
Interferon regulatory factor 4 binding protein is a novel p53 target gene and suppresses cisplatin-induced apoptosis of breast cancer cells. Mol Cancer (2012) 0.92
Estrogen protection in Friedreich's ataxia skin fibroblasts. Endocrinology (2011) 0.92
Overexpression of ORCA3 and G10H in Catharanthus roseus plants regulated alkaloid biosynthesis and metabolism revealed by NMR-metabolomics. PLoS One (2012) 0.92
Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution. Retrovirology (2008) 0.92
Molecular recognition remolds the self-assembly of hydrogelators and increases the elasticity of the hydrogel by 10(6)-fold. J Am Chem Soc (2004) 0.92
Influence of different sizes of titanium dioxide nanoparticles on hepatic and renal functions in rats with correlation to oxidative stress. J Toxicol Environ Health A (2009) 0.92
Tuned with a Tune: Talker Normalization via General Auditory Processes. Front Psychol (2012) 0.92
Interaction between polymorphisms of DNA repair genes significantly modulated bladder cancer risk. Int J Med Sci (2012) 0.91
Neuroendocrine mechanism for tolerance to cerebral ischemia-reperfusion injury in male rats. J Neurobiol (2005) 0.91
Estrogens as protectants of the neurovascular unit against ischemic stroke. Curr Drug Targets CNS Neurol Disord (2005) 0.91
Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus. Biochemistry (2004) 0.90
GPS-ARM: computational analysis of the APC/C recognition motif by predicting D-boxes and KEN-boxes. PLoS One (2012) 0.90
Retracted Spatially selective photochemical reduction of silver on nanoembossed ferroelectric PZT nanowires. Langmuir (2011) 0.89
Cell-cycle regulators are involved in transient cerebral ischemia induced neuronal apoptosis in female rats. FEBS Lett (2005) 0.88
Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study. Medicine (Baltimore) (2015) 0.88
Window of opportunity: estrogen as a treatment for ischemic stroke. Brain Res (2013) 0.88
Transient focal cerebral ischemia induces long-term cerebral vasculature dysfunction in a rodent experimental stroke model. Transl Stroke Res (2012) 0.88
Inhibition of endoplasmic reticulum stress by intermedin(1-53) protects against myocardial injury through a PI3 kinase-Akt signaling pathway. J Mol Med (Berl) (2011) 0.88
Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin. Int J Nanomedicine (2011) 0.88
Embolic middle cerebral artery occlusion model using thrombin and fibrinogen composed clots in rat. J Neurosci Methods (2012) 0.87